Skip to main content
Medrx Co.,Ltd. logo

Medrx Co.,Ltd. — Investor Relations & Filings

Ticker · 4586 ISIN · JP3921220004 T Manufacturing
Open in API
Filings indexed 79 across all filing types
Latest filing 2023-08-10 Interim / Quarterly Rep…
Country JP Japan
Listing T 4586

About Medrx Co.,Ltd.

https://www.medrx.co.jp/english/

Medrx Co., Ltd. is a pharmaceutical formulation development company that specializes in creating new dosage forms of medicines. The company's core focus is its transdermal absorption technology, which is used to develop innovative drug delivery systems like patches. These products are designed to improve patient health and quality of life (QOL) by providing alternatives for medications that are difficult to administer orally or by helping to prevent patients from forgetting to take their medicine. Medrx is actively engaged in research and development, managing a pipeline of pharmaceutical candidates that utilize its proprietary formulation technologies.

Recent filings

Filing Released Lang Actions
四半期報告書－第22期第2四半期(2023/04/01－2023/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a Japanese '四半期報告書' (Quarterly Report) filed with the Shikoku Finance Bureau. It contains detailed financial statements, management analysis (MDA), and business updates for the second quarter of the 22nd fiscal period (April 1, 2023, to June 30, 2023). As it is a comprehensive financial report for a period shorter than a full fiscal year, it falls under the 'Interim / Quarterly Report' category. H1 2023
2023-08-10 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act in Japan. It specifically confirms the accuracy of the contents of a Quarterly Report (Shihanki Hokokusho) for the first quarter of the 22nd fiscal period. Since this is a regulatory filing confirming the validity of a report rather than the report itself, and it does not fit into the specific categories like 10-K or IR, it falls under the general regulatory filing category.
2023-05-12 Japanese
四半期報告書－第22期第1四半期(2023/01/01－2023/03/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed by Medrx Co., Ltd. in accordance with the Financial Instruments and Exchange Act of Japan. It contains comprehensive financial statements, management's discussion and analysis (MD&A), and details on business operations for the first quarter of the 22nd fiscal period (January 1, 2023, to March 31, 2023). As it is a formal, comprehensive financial report for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. Q1 2023
2023-05-12 Japanese
確認書
Audit Report / Information Classification · 95% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act of Japan. It is a mandatory attachment to the Annual Securities Report (Yukashoken Hokokusho) where the CEO and CFO certify the accuracy of the report's contents. Since it is a regulatory filing required by law to accompany the annual report but is not the annual report itself, and does not fit into other specific categories like 'RPA' or '10-K', it is classified as a Regulatory Filing (RNS). FY 2022
2023-03-28 Japanese
内部統制報告書－第21期(2022/01/01－2022/12/31)
Governance Information Classification · 100% confidence The document is an 'Internal Control Report' (内部統制報告書) filed under the Financial Instruments and Exchange Act in Japan. It details the framework, scope, and results of the company's internal controls over financial reporting. This type of document is a standalone audit-related regulatory filing concerning internal control systems, which falls under the 'Audit Report / Information' category.
2023-03-28 Japanese
有価証券報告書－第21期(2022/01/01－2022/12/31)
Annual Report Classification · 100% confidence The document is a Japanese '有価証券報告書' (Yuuka Shouken Houkokusho), which is the standard Japanese equivalent of an Annual Report (10-K). It includes detailed financial tables, business indicators, and corporate information for the fiscal year ending December 31, 2022. It is a comprehensive report rather than an announcement or a summary. FY 2022
2023-03-28 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.